Clinical trial
Effects of Recombinant IGF-I in HIV Associated Metabolic Disease
NCT01329744 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Recombinant IGF-I in HIV Associated Metabolic Disease
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- June 30, 2011
- Completion date
- June 30, 2013
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv lipodystrophy